158 related articles for article (PubMed ID: 30881493)
1. Expression and prognostic significance of Fanconi anemia group D2 protein and breast cancer type 1 susceptibility protein in familial and sporadic breast cancer.
Feng L; Jin F
Oncol Lett; 2019 Apr; 17(4):3687-3700. PubMed ID: 30881493
[TBL] [Abstract][Full Text] [Related]
2. Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer.
van der Groep P; Hoelzel M; Buerger H; Joenje H; de Winter JP; van Diest PJ
Breast Cancer Res Treat; 2008 Jan; 107(1):41-7. PubMed ID: 17333336
[TBL] [Abstract][Full Text] [Related]
3. Overabundant FANCD2, alone and combined with NQO1, is a sensitive marker of adverse prognosis in breast cancer.
Fagerholm R; Sprott K; Heikkinen T; Bartkova J; Heikkilä P; Aittomäki K; Bartek J; Weaver D; Blomqvist C; Nevanlinna H
Ann Oncol; 2013 Nov; 24(11):2780-5. PubMed ID: 23897704
[TBL] [Abstract][Full Text] [Related]
4. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
[TBL] [Abstract][Full Text] [Related]
5. Expression of FANCD2 in sporadic breast cancer and clinicopathological analysis.
Zhang B; Chen R; Lu J; Shi Q; Zhang X; Chen J
J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):322-5. PubMed ID: 20556575
[TBL] [Abstract][Full Text] [Related]
6. The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features.
Barroso E; Pita G; Arias JI; Menendez P; Zamora P; Blanco M; Benitez J; Ribas G
Breast Cancer Res Treat; 2009 Dec; 118(3):655-60. PubMed ID: 19536649
[TBL] [Abstract][Full Text] [Related]
7. Utility of DNA repair protein foci for the detection of putative BRCA1 pathway defects in breast cancer biopsies.
Willers H; Taghian AG; Luo CM; Treszezamsky A; Sgroi DC; Powell SN
Mol Cancer Res; 2009 Aug; 7(8):1304-9. PubMed ID: 19671671
[TBL] [Abstract][Full Text] [Related]
8. Significance of the Fanconi anemia FANCD2 protein in sporadic and metastatic human breast cancer.
Rudland PS; Platt-Higgins AM; Davies LM; de Silva Rudland S; Wilson JB; Aladwani A; Winstanley JH; Barraclough DL; Barraclough R; West CR; Jones NJ
Am J Pathol; 2010 Jun; 176(6):2935-47. PubMed ID: 20363922
[TBL] [Abstract][Full Text] [Related]
9. BRCA1-independent ubiquitination of FANCD2.
Vandenberg CJ; Gergely F; Ong CY; Pace P; Mallery DL; Hiom K; Patel KJ
Mol Cell; 2003 Jul; 12(1):247-54. PubMed ID: 12887909
[TBL] [Abstract][Full Text] [Related]
10. FANCD2 Maintains Fork Stability in BRCA1/2-Deficient Tumors and Promotes Alternative End-Joining DNA Repair.
Kais Z; Rondinelli B; Holmes A; O'Leary C; Kozono D; D'Andrea AD; Ceccaldi R
Cell Rep; 2016 Jun; 15(11):2488-99. PubMed ID: 27264184
[TBL] [Abstract][Full Text] [Related]
11. FANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisons.
Kachnic LA; Li L; Fournier L; Ferraiolo N; Dahm-Daphi J; Borgmann K; Willers H
Cancer Lett; 2011 Jun; 305(1):86-93. PubMed ID: 21414716
[TBL] [Abstract][Full Text] [Related]
12. Coordination of the recruitment of the FANCD2 and PALB2 Fanconi anemia proteins by an ubiquitin signaling network.
Bick G; Zhang F; Meetei AR; Andreassen PR
Chromosoma; 2017 Jun; 126(3):417-430. PubMed ID: 27277787
[TBL] [Abstract][Full Text] [Related]
13. The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange.
Wilson JB; Johnson MA; Stuckert AP; Trueman KL; May S; Bryant PE; Meyn RE; D'Andrea AD; Jones NJ
Carcinogenesis; 2001 Dec; 22(12):1939-46. PubMed ID: 11751423
[TBL] [Abstract][Full Text] [Related]
14. Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability.
Bogliolo M; Lyakhovich A; Callén E; Castellà M; Cappelli E; Ramírez MJ; Creus A; Marcos R; Kalb R; Neveling K; Schindler D; Surrallés J
EMBO J; 2007 Mar; 26(5):1340-51. PubMed ID: 17304220
[TBL] [Abstract][Full Text] [Related]
15. siRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cells.
Bruun D; Folias A; Akkari Y; Cox Y; Olson S; Moses R
DNA Repair (Amst); 2003 Sep; 2(9):1007-13. PubMed ID: 12967657
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.
Garcia-Higuera I; Taniguchi T; Ganesan S; Meyn MS; Timmers C; Hejna J; Grompe M; D'Andrea AD
Mol Cell; 2001 Feb; 7(2):249-62. PubMed ID: 11239454
[TBL] [Abstract][Full Text] [Related]
17. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
[TBL] [Abstract][Full Text] [Related]
18. FANCD2 associated with sporadic breast cancer risk.
Barroso E; Milne RL; Fernández LP; Zamora P; Arias JI; Benítez J; Ribas G
Carcinogenesis; 2006 Sep; 27(9):1930-7. PubMed ID: 16679306
[TBL] [Abstract][Full Text] [Related]
19. High-risk human papillomavirus oncogenes disrupt the Fanconi anemia DNA repair pathway by impairing localization and de-ubiquitination of FancD2.
Khanal S; Galloway DA
PLoS Pathog; 2019 Feb; 15(2):e1007442. PubMed ID: 30818369
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathogenesis of fanconi anemia.
Taniguchi T; Dandrea AD
Int J Hematol; 2002 Feb; 75(2):123-8. PubMed ID: 11939257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
